It seems the medical drama 'Best Medicine' is carving out a significant niche for itself on Fox, and personally, I find this trend incredibly telling about the current television landscape. The network's decision to not only renew the show but also increase its episode order for the upcoming season speaks volumes about its perceived value and audience connection.
A Boost in Episodes: More Than Just a Number
What makes the increased episode count from 13 to 14 particularly fascinating is that it comes at a time when Fox is actually expanding its scripted offerings. This isn't a situation where they're filling a void; they're actively choosing to invest more in 'Best Medicine' amidst a competitive environment. In my opinion, this signals a strong vote of confidence from the network, suggesting they see genuine potential for growth and sustained viewership. It's a subtle but powerful indicator that the show is hitting its mark.
From Midseason to Fall: A Strategic Power Move
Moving 'Best Medicine' to the fall schedule, once again paired with 'Doc' on Tuesdays, is a strategic play that I think many viewers might overlook. Fox's scheduling chief, Dan Harrison, referred to it as "a night of medical marvels," and from my perspective, this isn't just marketing fluff. It's about creating a destination block for a specific type of viewer. This pairing suggests a deliberate effort to build a loyal audience around a shared genre, rather than scattering shows across the week. What this really suggests is a desire to cultivate appointment viewing in an era often dominated by binge-watching and fragmented attention spans.
Surging Viewership: The Unfolding Success Story
The numbers for 'Best Medicine' are quite compelling. Its premiere has climbed to 15 million multi-platform viewers, and more importantly, it was the only scripted series this season to grow in total viewers from its debut to its second episode. This kind of organic growth, especially when launching behind the NFL, is a rare and valuable commodity. Personally, I think this indicates a show that is not only attracting initial interest but is also successfully retaining and engaging its audience. It’s a testament to the show's ability to hook viewers and keep them coming back for more, which is the holy grail for any network.
The 'Doc Martin' Legacy and American Adaptation
As an adaptation of the beloved British series 'Doc Martin,' 'Best Medicine' carries a certain legacy. However, what makes its U.S. success particularly interesting is how it has managed to translate that charm and character-driven storytelling to an American audience. Liz Tuccillo, who developed the U.S. version and serves as showrunner, clearly has a knack for capturing the essence of the original while making it feel fresh and relevant. This adaptation success story raises a deeper question: what is it about certain international formats that resonate so strongly when transplanted, and what are the key ingredients for making that transition seamless?
Looking Ahead: A Promising Trajectory
Ultimately, the story of 'Best Medicine's' increased order and prime fall placement is one of a show finding its footing and exceeding expectations. It’s a reminder that compelling characters and well-crafted narratives can still capture the public's imagination. What many people don't realize is the immense pressure and intricate planning that goes into these scheduling decisions. For 'Best Medicine' to not only survive but thrive in this environment is a significant achievement. I'm genuinely curious to see how this momentum carries into its next season and if it can continue to deliver those "medical marvels" Fox is banking on.
